Steering Group

Who is involved in REACT-ANZ?

Our Steering Group includes:

Associate Professor Neil Johnson MBBS BMedSci FRANZCOG FRCOG MRCGP CREI

Neil is Associate Professor in Obstetrics & Gynaecology at the University of Auckland and Gynaecologist at National Women’s Health. He is a Subspecialist in REI with Fertility Plus (with whom he is Medical Director) and IVF-Auckland, an editor for the Cochrane Menstrual Disorders & Subfertility Group and for ANZJOG, and board member for the New Zealand Endometriosis Foundation and World Endometriosis Society. Current research interests include endometriosis, PCOS, unexplained infertility, ovarian reserve, diagnostic test accuracy studies and surgical clinical trials. Neil has been involved in RCTs evaluating LUNA (laparoscopic uterine nerve ablation), LOD (laparoscopic ovarian drilling) versus gonadotrophins for PCOS, balloon thermal ablation versus levonorgestrel intrauterine system for women with menorrhagia, lipiodol flushing (the FLUSH Trial – Flushing with Lipiodol for Unexplained Subfertility by Hysterosalpingography; the LUBE Study – Lipiodol Uterine Bathing Effect). Neil was PI for PCOSMIC (PolyCystic Ovary Syndrome – Metformin for Infertility with Clomiphene), with the REACT-NZ forerunner for the REACT-ANZ Group.

Dr Clare Boothroyd MBBS (Hons) MMedSci FRACP FRANZCOG CREI

Clare Boothroyd, a Queensland graduate with first class honours, has completed specialty training in both Medicine (Endocrinology) and in Obstetrics and Gynaecology. She has completed her subspecialty qualification in Reproductive Endocrinology and Infertility (CREI). She has been committed to evidence based practice and is a reviewer of the Cochrane Menstrual Disorders and Subfertility Group. Her research interests have been mutation analysis in endocrine disease, ovulation induction and unexplained infertility. Her practice is based at Greenslopes Private Hospital.

Dr Michael Costello MBBS MMed (RH&HG) FRANZCOG CREI

Michael is a Senior Lecturer in Obstetrics and Gynaecology at the University of New South Wales and Gynaecologist with subspecialty certification in Reproductive Endocrinology and Infertility (CREI) at the Royal Hospital for Women in Sydney, Australia. He is also a clinical consultant with IVFAustralia and editor for the Cochrane Menstrual Disorders & Subfertility Group. He has a strong interest in evidence-based medicine and his main research interests include Assisted Reproductive Treatments (including Intra-Uterine Insemination and IVF) and Polycystic Ovary Syndrome.

Professor Cindy Farquhar MB ChB MD FRCOG FRANZCOG CREI MPH MNZM

Cindy is the Postgraduate Professor of Obstetrics and Gynaecology in the Department of Obstetrics and Gynecology at the University of Auckland. She is the coordinating editor of the Cochrane Menstrual Disorders and Subfertility Group which was established in 1996. Her research interests include clinical trials within subfertility and menstrual disorders, systematic reviews and clinical practice guidelines. In 2000, Cindy was a Harkness Fellow for the Commonwealth Fund and spent one year at the Agency for Healthcare Research and Quality in Maryland. Her clinical interests are polycystic ovarian syndrome, pelvic pain, endometriosis and the management of abnormal uterine bleeding. Cindy has led guideline development groups on heavy menstrual bleeding, uterine fibroids and the management of women with breech presentation and vaginal birth after caesarean section, as well as assisting with training in guideline development workshops in NZ. She is the chair of the board of the NZ Guidelines Group (www.nzgg.org.nz) and Chair of the newly established Perinatal and Maternal Mortality Review Committee (http://www.newhealth.govt.nz/pmmrc/).

Associate Professor Roger Hart

Roger Hart is a UK trained sub-specialist in reproductive medicine. He migrated to Australia in 2003 to take up a position with the University of Western Australia. He wrote his MD on the development of a novel method of hysteroscopic sterilisation, he has received certification in Reproductive Endocrinology and Infertility (CREI) from the Royal Australian and New Zealand College of Obstetricians and Gynaecologists and has research interests in gynaecological endoscopic surgery, PCOS, endometriosis and the influence of early life events on reproduction. He is an Associate Editor of the Australian and New Zealand Journal of Obstetrics and Gynaecology and part of the Cochrane Menstrual and Disorders and Infertility Group. He is the medical director of Fertility Specialists of Western Australia.

Dr Luk Rombauts MD PhD FRANZCOG CREI

After spending 2 years at the Leuven Institute of Fertility and Embryology (Belgium), where he helped develop the Transvaginal Hydrolaparoscopy technique, Luk returned to Melbourne in 1998 to obtain his Certificate of Reproductive Endocrinology and Infertility (CREI). He is now accredited by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as a training supervisor for the CREI.

Luk is the Clinical Director of the Monash IVF program in Clayton. He is a Senior Medical Consultant in the Reproductive Medicine Unit at Monash Medical Centre and holds an appointment as Senior Lecturer in the Department of Obstetrics and Gynaecology at Monash University.

He directs clinical research projects at Monash IVF and has a special interest in mechanisms of embryo implantation and endometriosis. In 2002, Luk founded AWARE (Australian Working-party to Advance Research into Endometriosis) and he is a board member for the World Endometriosis Society.

Dr James Moir

James Moir is an Obstetrician and Gynaecologist as well as the Clinical Director of IVF Sunshine Coast. James qualified in Aberdeen, Scotland, in June 1975. Early in his career, he spent 7 years working as a Medical Officer and Scientific Research Officer in Papua New Guinea. After completing an MSc degree at the London School of Hygiene and Tropical Medicine in 1986, he returned to the field of Obstetrics and Gynaecology, obtaining his specialist qualification in Australia in December 1994. He has been associated with IVF Sunshine coast since 1996, and Clinical Director since 1999. IVF Caboolture opened in early 2008. Dr James Moir is married with 4 children.

Dr Martyn Stafford-Bell MBBS (Lon), FRCOG, FRANZCOG

Martyn qualified in the UK. He worked as a registrar in O&G at The Royal London Hospital 1969-71, and then Senior Registrar in O & G at Guy’s Hospital, London 1972-74. In 1975 he established a private practice in Canberra.. Martyn co-founded the Canberra Fertility Centre in 1985 and was a co-founder and board member of The World Endometriosis Research Foundation. His main areas of interest are the investigation and management of infertility and endometriosis.

Dr Kelton Tremellen MB BS (Hons) PhD FRANZCOG CREI Grad Cert Mgmt

Dr Tremellen completed his training in Obstetrics and Gynaecology in 2001, before commencing sub-specialty training in Reproductive Endocrinology and Infertility (CREI). After three years of sub-specialty training in all surgical and medical aspects of infertility treatment he became a clinical director at Repromed. He completed a PhD in reproductive immunology at the University of Adelaide in 1999. The focus of his studies was on why some women’s immune systems “reject” their baby, leading to miscarriage and IVF failure. As such, Dr Tremellen has a keen clinical interest in investigation and management of recurrent miscarriage and IVF failure.

Dr Tremellen is the inventor of two recent innovations in the field of reproductive medicine; the “Egg Timer” and the male fertility pill “Menevit”. The Egg Timer is a combination of a blood test and pelvic ultrasound which help determine how many good quality eggs remain within a woman’s ovaries. This test has now become a routine investigation for all women attending Repromed’s fertility clinic and is also becoming an increasingly popular aide to help women plan when to have a baby. Menevit is a male fertility pill invented by Dr Tremellen and developed in collaboration with Bayer Australia. It has been shown in research studies conducted at Repromed (Menevit trial and the ADAM study) to reduce sperm DNA damage and boost IVF pregnancy rates. Dr Tremellen is a member of the Fertility Society of Australia (FSA) and the American Society for Reproductive Medicine (ASRM). He is an author of several journal articles, 3 book chapters and an inventor on three patents.